AME Medical Doubles Capital With 70M SAR Bonus Issue

Riyadh, Saudi Arabia — AME Company for Medical Supplies plans to double its share capital, issuing one bonus share for every share held. The board resolved on November 1, 2026 to recommend the move to an Extraordinary General Assembly. The capital increase converts 70 million SAR from retained earnings into paid-up capital, lifting the total from 70 million SAR to 140 million SAR.

Deal Details

The bonus issue raises the share count from 7 million to 14 million shares — a clean 100% increase. Shareholders registered in the Edaa depository at the end of the second trading day after the Extraordinary General Assembly will qualify for the new shares. AME has not yet set a date for that assembly, pending regulatory approval from the Capital Market Authority.

Fractional shares will not be distributed individually. Instead, AME will pool all fractions into a single portfolio, sell them at market price, and distribute the cash proceeds to eligible shareholders within 30 days of final share allocation.

Why It Matters

• AME cited alignment with operational scale and strategic objectives as the rationale for strengthening its capital base.
• The full 70 million SAR comes from retained earnings — no new cash is raised and no dilution of economic value occurs per share on a proportional basis.
• CMA approval and an Extraordinary General Assembly vote are both required before the increase takes effect.
• The eligibility date ties directly to the assembly date, which remains to be announced.

What This Means for Investors

• Existing shareholders receive one new share per share held, but the share price should adjust proportionally — leaving total portfolio value unchanged at the moment of issuance.
• The transfer from retained earnings reduces the company’s distributable reserves by 70 million SAR, which could affect future dividend capacity.
• Liquidity in the stock may improve as the float doubles in share count, though market depth depends on actual trading activity after issuance.
• Investors should watch for the CMA approval announcement and the Extraordinary General Assembly date — both are necessary steps before any shares change hands.

Saudi Arabia capital markets news and analysis

Latest investor news from the Saudi stock market

THE SAUDI STANDARD’S VIEW: AME’S CAPITAL DOUBLING — SIGNAL OR SMOKE?

AME Company for Medical Supplies has moved to double its paid-up capital through a bonus share issuance funded entirely from retained earnings, bringing its capital base to 140 million SAR. While the mechanics are straightforward, the strategic implications for investors require a more disciplined read than the headline number suggests.

• RETAINED EARNINGS AS CAPITAL — A TRADE-OFF WITH CONSEQUENCES

Converting 70 million SAR from retained earnings into paid-up capital is a non-cash transaction that reconfigures the company’s balance sheet without injecting fresh liquidity. The practical consequence is a permanent reduction in the reserves available for future dividend distributions. Investors who prioritize income over capital structure optics should factor this trade-off into their position sizing.

• LIQUIDITY OPTIONALITY, NOT GUARANTEED DEPTH

Doubling the share count from 7 million to 14 million shares mechanically expands the float, which can lower the barrier to entry for institutional participants who require minimum trading volumes. However, improved liquidity is a potential outcome contingent on sustained market interest — a larger share count alone does not manufacture buyer demand. Investors should assess average daily trading volumes in the weeks following issuance before drawing conclusions.

• REGULATORY SEQUENCING CREATES A DEFINED RISK WINDOW

Both CMA regulatory approval and an Extraordinary General Assembly vote must be secured before this issuance takes legal effect. This two-gate structure introduces timing uncertainty that could extend the period between the board resolution and actual share distribution by several months. Active traders should treat the current period as a waiting phase, not a confirmation of execution.

• MEDICAL SUPPLIES SECTOR — CAPITAL STRUCTURE AS A COMPETITIVE SIGNAL

A strengthened capital base in the medical supplies sector carries strategic weight in the Saudi context, where healthcare infrastructure expansion is a government-prioritized objective. A larger paid-up capital can enhance AME’s standing in procurement processes, financing negotiations, and potential partnership discussions with public health entities. The board’s rationale of aligning capital with operational scale reflects awareness of the competitive dynamics in a sector increasingly shaped by large-scale government contracts.

Saudi Arabia’s healthcare sector is a cornerstone of Vision 2030’s economic diversification ambition, with billions committed to expanding domestic medical capacity and reducing dependence on imported healthcare services. AME’s decision to fortify its capital structure positions the company to participate more credibly in that expanding landscape. For investors with a medium-to-long horizon, the more meaningful question is not what the bonus issue does to today’s share price — which adjusts proportionally — but whether AME’s operational strategy can convert a stronger balance sheet into measurable revenue growth within a sector that Vision 2030 has structurally favored.